Cargando…
Utilizing gastric cancer organoids to assess tumor biology and personalize medicine
While the incidence and mortality of gastric cancer (GC) have declined due to public health programs, it remains the third deadliest cancer worldwide. For patients with early disease, innovative endoscopic and complex surgical techniques have improved survival. However, for patients with advanced di...
Autores principales: | Lin, Miranda, Gao, Mei, Cavnar, Michael J, Kim, Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657221/ https://www.ncbi.nlm.nih.gov/pubmed/31367270 http://dx.doi.org/10.4251/wjgo.v11.i7.509 |
Ejemplares similares
-
Genetics of scleroderma: implications for personalized medicine?
por: Assassi, Shervin, et al.
Publicado: (2013) -
Past, Present, and Future of Brain Organoid Technology
por: Koo, Bonsang, et al.
Publicado: (2019) -
Neural Organoids, a Versatile Model for Neuroscience
por: Lee, Ju-Hyun, et al.
Publicado: (2022) -
Personalized medicine and atrial fibrillation: will it ever happen?
por: Lubitz, Steven A, et al.
Publicado: (2012) -
Personalized medicine in multiple sclerosis: hope or reality?
por: Derfuss, Tobias
Publicado: (2012)